Nephrostomy Workup

  • Author: Stefan H Hautmann, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS   more...
 
Updated: Dec 1, 2011
 

Laboratory Studies

  • Bleeding time, as indicated
  • Prothrombin time
  • Platelet count
  • Activated partial thromboplastin time (aPTT)
  • CBC count
  • Urine culture
  • Electrolyte assessment
  • Creatinine assessment
Next

Imaging Studies

Any of the following studies can be used to assess patient anatomy:

  • Intravenous pyelography (IVP)
  • Abdominal CT scanning, shown in the images below
  • Renal ultrasonographyCT scan of bilateral hydronephrotic kidneys withouCT scan of bilateral hydronephrotic kidneys without intravenous contrast medium. CT scan with dilated right ureter without intravenCT scan with dilated right ureter without intravenous contrast medium.
Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Stefan H Hautmann, MD  Professor of Urology, Department of Urology and Pediatric Urology, Hospital of Luedenscheid, Academic Hospital of the University of Bonn, Germany

Disclosure: Nothing to disclose.

Coauthor(s)

Raymond J Leveillee, MD, FRCS(Glasg)  Professor of Clinical Urology, Radiology and Biomedical Engineering, Department of Urology, University of Miami Miller School of Medicine; Chief, Division of Endourology/Laparoscopy and Minimally Invasive Surgery, Department of Urology, Jackson Memorial Hospital

Raymond J Leveillee, MD, FRCS(Glasg) is a member of the following medical societies: American Urological Association, Endourological Society, Sigma Xi, and Society of Laparoendoscopic Surgeons

Disclosure: ACMI/Gyrus Honoraria Speaking and teaching; Boston Scientific Honoraria Speaking and teaching; Applied Medical Honoraria Speaking and teaching; Intuitive Surgical Honoraria Speaking and teaching; Intio Grant/research funds Other

Specialty Editor Board

Raymond Rackley, MD  Professor of Surgery, Cleveland Clinic Lerner College of Medicine; Staff Physician, Center for Pelvic Medicine and Pelvic Reconstruction, Glickman Urological Institute, Joint Appointment with Women's Institute Cleveland Clinic Foundation

Raymond Rackley, MD is a member of the following medical societies: American Urological Association

Disclosure: Pfizer, Novartis, Proctor & Gamble, Allergan Honoraria None; Pfizer, Novartis, Proctor & Gamble, Allergan Consulting fee Other

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Shlomo Raz, MD  Professor, Department of Surgery, Division of Urology, University of California at Los Angeles School of Medicine

Shlomo Raz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, and California Medical Association

Disclosure: Nothing to disclose.

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

References

  1. Goodwin WE, Casey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. J Am Med Assoc. Mar 12 1955;157(11):891-4. [Medline].

  2. Fernström I, Johansson B. Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol. 1976;10(3):257-9. [Medline].

  3. Alken P, Hutschenreiter G, Gunther R, et al. Percutaneous stone manipulation. J Urol. Apr 1981;125(4):463-6. [Medline].

  4. Parikh GP, Shah VR, Modi MP, Chauhan NC. The analgesic efficacy of peritubal infiltration of 0.25% bupivacaine in percutaneous nephrolithotomy - A prospective randomized study. J Anaesthesiol Clin Pharmacol. Oct 2011;27(4):481-4. [Medline]. [Full Text].

  5. Ozok HU, Sagnak L, Senturk AB, Karakoyunlu N, Topaloglu H, Ersoy H. A Comparison of Metal Telescopic Dilators and Amplatz Dilators for Nephrostomy Tract Dilation in Percutaneous Nephrolithotomy. J Endourol. Oct 14 2011;[Medline].

  6. Li CC, Li JR, Huang LH, Hung SW, Yang CK, Wang SS, et al. Metallic stent in the treatment of ureteral obstruction: Experience of single institute. J Chin Med Assoc. Oct 2011;74(10):460-3. [Medline].

  7. Biyani CS, O'Connor JP, Browning AJ. Laparoscopic removal of retained nephrostomy tubing. J Urol. Sep 2003;170(3):916-7. [Medline].

  8. Bloom DA, Morgan RJ, Scardino PL. Thomas Hillier and percutaneous nephrostomy. Urology. Apr 1989;33(4):346-50. [Medline].

  9. Carson CC, Little N. The absolute and relative contraindications to ESWL. In: Problems in Urology. Vol 1. Philadelphia, Pa: JB Lippincott Co; 1987:580.

  10. Clayman RV, Kavoussi LR. Endosurgical techniques for noncalculous disease. In: Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders Co; 1992:2235-45.

  11. Coleman CC, Kimura Y, Reddy P. Complications of nephrostolithotomy. Sem Intervent Radiol. 1984;1:24.

  12. Grasso M, Loisides P, Beaghler M, et al. The case for primary endoscopic management of upper urinary tract calculi: I. A critical review of 121 extracorporeal shock-wave lithotripsy failures. Urology. Mar 1995;45(3):363-71. [Medline].

  13. Grasso MG, Taylor F. Techniques for percutaneous renal access. In: Sosa RE, Albala DM, eds. Textbook of Endourology. Philadelphia, Pa: WB Saunders Co; 1996.

  14. Kaskarelis IS, Papadaki MG, Malliaraki NE, et al. Complications of percutaneous nephrostomy, percutaneous insertion of ureteral endoprosthesis, and replacement procedures. Cardiovasc Intervent Radiol. Jul-Aug 2001;24(4):224-8. [Medline].

  15. Kavanagh DO, Fanning N, Heffernan E, et al. Management of gestational nephrolithiasis in the presence of a bicornuate uterus and pelvic kidney. Int J Urol. Feb 2005;12(2):211-3. [Medline].

  16. Kukreja R, Desai M, Patel S, et al. Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol. Oct 2004;18(8):715-22. [Medline].

  17. Lam HS, Lingeman JE, Mosbaugh PG, et al. Evolution of the technique of combination therapy for staghorn calculi: a decreasing role for extracorporeal shock wave lithotripsy. J Urol. Sep 1992;148(3 Pt 2):1058-62. [Medline].

  18. LeRoy AJ, Williams HJ Jr, Bender CE, et al. Colon perforation following percutaneous nephrostomy and renal calculus removal. Radiology. Apr 1985;155(1):83-5. [Medline].

  19. Little B, Ho KJ, Gawley S, et al. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy. Int J Clin Pract. Apr 2003;57(3):180-1. [Medline].

  20. Mariappan P, Smith G, Bariol SV, et al. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol. May 2005;173(5):1610-4. [Medline].

  21. Motola JA, Smith AD. Therapeutic options for the management of upper tract calculi. Urol Clin North Am. Feb 1990;17(1):191-206. [Medline].

  22. Picus D, Weyman PJ, Clayman RV, et al. Intercostal-space nephrostomy for percutaneous stone removal. AJR Am J Roentgenol. Aug 1986;147(2):393-7. [Medline].

  23. Segura JW. Percutaneous management. In: Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders; 1992:2183-94.

  24. Segura JW, Preminger GM, Assimos DG, et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. Jun 1994;151(6):1648-51. [Medline].

  25. Smith AD. Management of iatrogenic ureteral strictures after urological procedures. J Urol. Dec 1988;140(6):1372-4. [Medline].

  26. Strohmaier WL, Giese A. Ex vivo training model for percutaneous renal surgery. Urol Res. Jun 2005;33(3):191-3. [Medline].

  27. Tanaka T, Yanase M, Takatsuka K. Clinical course in patients with percutaneous nephrostomy for hydronephrosis associated with advanced cancer. Hinyokika Kiyo. Jul 2004;50(7):457-62. [Medline].

  28. Whitaker RH. An evaluation of 170 diagnostic pressure flow studies of the upper urinary tract. J Urol. May 1979;121(5):602-4. [Medline].

  29. Zagoria RJ, Dyer RB. Do's and don't's of percutaneous nephrostomy. Acad Radiol. Jun 1999;6(6):370-7. [Medline].

 
Previous
Next
 
Renal anatomy.
Positioning of nephrostomy tube into the lower pole of the kidney.
Outside appearance of a nephrostomy tube from the flank after stone removal.
CT scan of bilateral hydronephrotic kidneys without intravenous contrast medium.
CT scan with dilated right ureter without intravenous contrast medium.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.